WallStreetZenWallStreetZen

NASDAQ: HRMY
Harmony Biosciences Holdings Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Harmony Biosciences Holdings revenue was $714.73M for the trailing 12 months ending Dec 31, 2024, with 18% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $201.3M, up 8.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HRMY annual revenue was $714.7M, with 22.8% growth year-over-year.

HRMY past revenue growth

How has HRMY's revenue growth performed historically?

Company
22.8%
Industry
497.69%
Market
20.68%
HRMY's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HRMY's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HRMY's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

HRMY revenue history

Current Revenue
$714.7M
Current Earnings
$145.5M
Current Profit Margin
20.4%

Be the first to know when HRMY announces revenue.

HRMY Revenue History By Year

HRMY Yearly RevenueHRMY RevenueHRMY ChangeHRMY Revenue Growth
2024-12-31$714.73M$132.71M+22.80%
2023-12-31$582.02M$144.17M+32.93%
2022-12-31$437.86M$132.42M+43.35%
2021-12-31$305.44M$145.70M+91.21%
2020-12-31$159.74M$153.75M+2,564.59%
2019-12-31$6.00MN/AN/A
2018-12-31$0.00N/AN/A

1 of 1

Harmony Biosciences Holdings Revenue FAQ

What was HRMY's revenue last quarter?

On Invalid Date, Harmony Biosciences Holdings (NASDAQ: HRMY) reported Q4 2024 revenue of $201.27 million up 19.51% year over year. In the same quarter last year, Harmony Biosciences Holdings's revenue was $168.41 million.

What was Harmony Biosciences Holdings's revenue in 2024?

Harmony Biosciences Holdings's annual revenue for the twelve months ending Dec 31, 2024 was $714.73 million, a 22.8% increase year over year.

How much does Harmony Biosciences Holdings make in a day?

Based on Harmony Biosciences Holdings annual revenue for the past five years, HRMY makes an average of $1,205,366.03 per day.

What was Harmony Biosciences Holdings's annual revenue growth in the past year?

As of Q2 2025, Harmony Biosciences Holdings's revenue has grown 22.8% year over year. This is 474.89 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Harmony Biosciences Holdings's revenue in the past year totaled $714.73 million.

How much does Harmony Biosciences Holdings make in a year?

Harmony Biosciences Holdings's revenue by year for the past five years is:
  • Harmony Biosciences Holdings's revenue for the twelve months ending Dec 31, 2024 was $714.73 million, a 22.8% increase year over year.
  • Harmony Biosciences Holdings's annual revenue for Dec 31, 2023 was $582.02 million, a 32.93% increase from 2022.
  • Harmony Biosciences Holdings's annual revenue for 2022 was $437.86 million, a 43.35% increase from 2021.
  • Harmony Biosciences Holdings's annual revenue for 2021 was $305.44 million, a 91.21% increase from 2020.
  • Harmony Biosciences Holdings's annual revenue for 2020 was $159.74 million, a 2,564.59% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.